Search

DexCom Inc

Closed

SectorHealthcare

86.5 -1.11

Overview

Share price change

24h

Current

Min

86.42

Max

87.13

Key metrics

By Trading Economics

Income

50M

249M

Sales

117M

1.3B

P/E

Sector Avg

35.245

55.725

EPS

0.7

Profit margin

19.039

Employees

11,000

EBITDA

52M

389M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+8.25% upside

Dividends

By Acuity

Next Earnings

29 Oct 2026

Market Stats

By TradingEconomics

Market Cap

5.3B

34B

Previous open

87.61

Previous close

86.5

News Sentiment

By Acuity

100%

0%

305 / 339 Healthcare

DexCom Inc Chart

Past performance is not a reliable indicator of future results.

Related News

25 Sept 2026, 20:07 UTC

Dexcom Inc shares fell sharply, continuing a downward trajectory and closing lower compared to Thursday, remaining below its 20-day moving average.

23 Sept 2026, 20:07 UTC

Dexcom Inc shares fell sharply after an earlier rise, reflecting a decline compared to Tuesday's close amid broader market weakness.

22 Sept 2026, 20:07 UTC

Dexcom Inc is seeing a modest gain, reflecting stability near the upper end of its one-month range and above its 20-day moving average.

18 Sept 2026, 20:07 UTC

News

Dexcom Inc shares are advancing as Truist Securities raised its price target to $102 and TD Cowen reiterated its Buy rating with a $95 target.

17 Sept 2026, 19:26 UTC

News

Dexcom's stock is higher as Truist Securities raises its price target to $102.00 from $93.00, maintaining a Buy rating.

16 Sept 2026, 20:10 UTC

Dexcom Inc is trading higher, reaching a peak in late morning and settling above Tuesday's close, marking three consecutive daily gains.

15 Sept 2026, 20:01 UTC

Dexcom Inc shares are trading higher amid broader market concerns following a significant decline in the NY Empire State Manufacturing Index.

10 Sept 2026, 19:36 UTC

Dexcom Inc shares are higher in Thursday's session, recovering from an initial dip. The stock remains below its 20-day moving average. No specific news identified.

9 Sept 2026, 22:11 UTC

Dexcom Inc shares are higher in after-market trading, reflecting a positive shift since Wednesday's close, despite recent lower closes and no specific news.

8 Sept 2026, 20:01 UTC

Dexcom Inc. shares are lower today, trading significantly below their 20-day moving average amid speculation of a potential Federal Reserve interest rate hike.

28 Aug 2026, 20:08 UTC

Dexcom Inc shares are higher today, aligning with a broader market increase. The asset is trading above its 20-day moving average.

26 Aug 2026, 19:16 UTC

Dexcom Inc's shares are higher today, reaching their peak around 14:50 ET. The stock remains above its 20-day moving average.

25 Aug 2026, 20:07 UTC

Dexcom Inc. shares are lower today amid broader market weakness. The stock remains above its 20-day moving average despite recent declines since Monday's close.

21 Aug 2026, 19:36 UTC

Social Media

Dexcom Inc shares are higher as $1.6 million in call options signals bullish investor sentiment. The stock has recovered from earlier session lows.

20 Aug 2026, 19:36 UTC

Dexcom Inc shares are higher today, continuing a three-session upward trend. The stock has fluctuated within a narrow range during regular trading hours.

19 Aug 2026, 19:41 UTC

Dexcom Inc shares are higher Wednesday, pulling back from an early peak. The stock is trading with unusually high volume and remains above its 20-day moving average.

18 Aug 2026, 19:16 UTC

Dexcom Inc shares are higher today, reflecting positive market sentiment despite no specific news. The stock remains above its 20-day moving average.

17 Aug 2026, 19:46 UTC

Dexcom Inc's shares are lower today, continuing a decline since Friday's close. No specific news has been identified to explain the price movement.

14 Aug 2026, 19:16 UTC

Dexcom Inc shares are lower today, continuing a decline since Thursday's close amid broader market caution following an unexpected drop in U.S. retail sales.

13 Aug 2026, 19:26 UTC

Dexcom Inc shares are higher today, despite an earlier pullback. The stock's advance contrasts with a broader market decline since the session's start.

12 Aug 2026, 19:36 UTC

Dexcom Inc shares are higher amid broader market optimism following inflation data. The core Consumer Price Index showed a modest increase, aligning with forecasts.

11 Aug 2026, 23:26 UTC

Dexcom Inc shares are trading lower in after-market hours. Broader market trends and cautious investor sentiment may be influencing this price movement.

10 Aug 2026, 20:02 UTC

Dexcom Inc shares are higher today, continuing an upward trend since Friday. The move occurs amid recent labor market data influencing investor sentiment.

7 Aug 2026, 23:46 UTC

Dexcom Inc shares are higher in after-market hours, continuing recent positive momentum. The stock remains well above its 20-day moving average.

5 Aug 2026, 19:51 UTC

News

Dexcom shares are declining amid negative sentiment in the insulin sector following Podd's revenue growth forecast cut. Broader economic data also influences cautious market sentiment.

4 Aug 2026, 19:56 UTC

Dexcom Inc. shares are lower today, pulling back after reaching a session high. The broader market benefits from a significant decline in crude oil prices.

3 Aug 2026, 20:02 UTC

News
Social Media

Dexcom Inc. shares are higher following strong Q2 results and raised revenue guidance to $5.22 billion. Canaccord increased its price target to $90.

31 Jul 2026, 20:04 UTC

News
Social Media

Dexcom Inc. shares are higher following analyst upgrades and strong earnings, with second-quarter revenue of $1.31 billion exceeding expectations and guidance raised to $5.22 billion.

30 Jul 2026, 23:51 UTC

News
Social Media

Dexcom reported second-quarter revenue of $1.308 billion and adjusted EPS of $0.70, raising its fiscal year 2026 revenue guidance, with shares trading higher in after-market hours.

29 Jul 2026, 23:41 UTC

Dexcom Inc is trading higher in after-market hours, supported by overall market strength. The asset remains above its 20-day moving average.

Peer Comparison

Price change

DexCom Inc Forecast

Price Target

By TipRanks

8.25% upside

12 Months Forecast

Average 93.765 USD  8.25%

High 105 USD

Low 82 USD

Based on 19 Wall Street analysts offering 12 month price targets forDexCom Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

18

Buy

1

Hold

0

Sell

Sentiment

By Acuity

305 / 339 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.